Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors.
The Italian Association of Haemophilia Centres reviewed and finally approved in November 2004 the new Italian Guidelines for the diagnosis and treatment of patients with clotting factor inhibitors. The recommendations have been based on the identification of levels of clinical evidence derived from the systematic review carried out in 2003 by the School of Health and Related Research, the University of Sheffield, UK, and further integrated by clinical studies published from 2003 to 2004. The Italian guidelines consist of six major domains concerning inhibitor definition, epidemiology, risk factors, diagnosis, inhibitor eradication, management of bleeding episodes, in patients with congenital and acquired coagulation disorders, with 121 statements, 59 synthesis and 54 recommendations. We report here recommendations and open issues concerning the diagnosis and monitoring of inhibitors, inhibitor eradication and the management of bleeding in patients with haemophilia A and B.
Gringeri
A
A
Department of Internal Medicine and Dermatology, Angelo Bianchi Bonomi Haemophilia and Thrombosis Centre, Milan, Italy. alessandro.gringeri@unimi.it
Mannucci
P M
PM
D000465:Algorithms; D001779:Blood Coagulation Factors / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D020147:Coagulation Protein Disorders / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D006467:Hemophilia A / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D006470:Hemorrhage / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007558:Italy; D012307:Risk Factors
D001779:Blood Coagulation Factors